CN119894520A - 皮肤外用剂组合物 - Google Patents

皮肤外用剂组合物 Download PDF

Info

Publication number
CN119894520A
CN119894520A CN202380065576.3A CN202380065576A CN119894520A CN 119894520 A CN119894520 A CN 119894520A CN 202380065576 A CN202380065576 A CN 202380065576A CN 119894520 A CN119894520 A CN 119894520A
Authority
CN
China
Prior art keywords
component
mass
composition
external
skin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202380065576.3A
Other languages
English (en)
Chinese (zh)
Inventor
中野大介
畠山勇生
横田和义
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zeria Pharmaceutical Co Ltd
Original Assignee
Zeria Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zeria Pharmaceutical Co Ltd filed Critical Zeria Pharmaceutical Co Ltd
Publication of CN119894520A publication Critical patent/CN119894520A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4166—1,3-Diazoles having oxo groups directly attached to the heterocyclic ring, e.g. phenytoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
CN202380065576.3A 2022-09-13 2023-09-13 皮肤外用剂组合物 Pending CN119894520A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2022-145110 2022-09-13
JP2022145110 2022-09-13
PCT/JP2023/033283 WO2024058193A1 (ja) 2022-09-13 2023-09-13 皮膚外用剤組成物

Publications (1)

Publication Number Publication Date
CN119894520A true CN119894520A (zh) 2025-04-25

Family

ID=90275130

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202380065576.3A Pending CN119894520A (zh) 2022-09-13 2023-09-13 皮肤外用剂组合物

Country Status (5)

Country Link
JP (1) JPWO2024058193A1 (enrdf_load_stackoverflow)
KR (1) KR20250065702A (enrdf_load_stackoverflow)
CN (1) CN119894520A (enrdf_load_stackoverflow)
TW (1) TW202417003A (enrdf_load_stackoverflow)
WO (1) WO2024058193A1 (enrdf_load_stackoverflow)

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5742621A (en) 1980-08-29 1982-03-10 Zenyaku Kogyo Kk Composition for oryzanol external pharmaceutical
JP2004308530A (ja) 2003-04-04 2004-11-04 Calsonic Compressor Seizo Kk 気体圧縮機
DE10359766A1 (de) 2003-12-19 2005-07-14 Dr.Ing.H.C. F. Porsche Ag An einem Fahrzeugboden anbringbare Fußstütze
JP2008231087A (ja) 2007-02-22 2008-10-02 Kose Corp 皮膚外用剤
JP6265624B2 (ja) * 2012-05-11 2018-01-24 ロート製薬株式会社 ルリコナゾール含有外用医薬組成物
JP6512599B2 (ja) 2015-03-30 2019-05-15 株式会社池田模範堂 外用医薬組成物
JP6920031B2 (ja) * 2016-06-30 2021-08-18 小林製薬株式会社 慢性角化型湿疹改善剤
JP7313111B2 (ja) * 2017-06-06 2023-07-24 小林製薬株式会社 皮脂分泌促進剤及び外用組成物

Also Published As

Publication number Publication date
KR20250065702A (ko) 2025-05-13
WO2024058193A1 (ja) 2024-03-21
JPWO2024058193A1 (enrdf_load_stackoverflow) 2024-03-21
TW202417003A (zh) 2024-05-01

Similar Documents

Publication Publication Date Title
JP7170385B2 (ja) 乳化組成物
JP2012136491A (ja) ウフェナマート含有皮膚外用剤
JP7170384B2 (ja) 乳化組成物
EP4021456A1 (en) Treatment of skin conditions using high krafft temperature anionic surfactants
TWI806867B (zh) 乳化組成物
JPH0459292B2 (enrdf_load_stackoverflow)
JP2003212716A (ja) 液晶型乳化組成物
JP7606104B2 (ja) 外用剤組成物
JP2009114081A (ja) Ｏ／ｗ乳化型皮膚外用組成物
TW202228713A (zh) 外用乳化組成物
WO2006029013A2 (en) Topical dermatological formulations and use thereof
CN119894520A (zh) 皮肤外用剂组合物
JP2017178867A (ja) 乳化組成物
CN101332183A (zh) 含有甾类化合物的o/w型乳化制剂
JP2021001138A (ja) 外用組成物
JP2021004187A (ja) 外用組成物
JP2021001137A (ja) 外用組成物
CN101053552A (zh) 含有泼尼松龙醋酸戊酸酯的o/w型乳化制剂
JP3803595B2 (ja) 尿素含有皮膚外用組成物
EP4108235B1 (en) Topical pharmaceutical formulation
JP2025095431A (ja) 外用組成物
JP4521899B2 (ja) クロタミトン含有皮膚外用液剤
JP7712737B1 (ja) オキサゾール化合物含有組成物
JP7642361B2 (ja) 外用医薬組成物
JP2023090338A (ja) 乳化組成物

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination